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ABSTRACT 
 
 This study was conducted as a preliminary step on the rabbits for comparative efficacy of different 
vaccines of Staphylococcus aureus. Typical alpha-beta Staph. aureus species from a clinically affected 
mastitic buffalo was isolated. After proper identification based on cultural and morphological 
characteristics and API-Staph Trac system, a selected Staph. aureus isolate was used to prepare four 
different  mastitis vaccines (Bacterin, oil-adjuvanted, dextran sulphate adjuvanted and live attenuated) after 
confirmation for pathogenicity and antigenicity, followed by its safety and sterility evaluation. Vaccines 
were tried in 25 rabbits divided into 5 equal groups. A separate vaccine was administered s/c @ 0.2 ml per 
animal and boosted at 15 days later. It was found that IHA antibody titers were higher (GMT 32-128) in 
live attenuated, dextran sulphate adjuvanted (GMT 32-128) and oil-adjuvanted (GMT 16-64) than the 
bacterin treated (GMT 16-32) group. All the vaccines showed an apparent immune response than the 
unvaccinated control group.  
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INTRODUCTION 
 
A common practice in rural household is to keep 
3–5 heads of buffaloes primarily for family use 
(Chaudhry, 1984). The animals are predominantly hand 
milked and contagious mastitis caused by Staph. aureus 
is most prevalent in Pakistan (Qamar, 1992; Fazal-ur-
Rehman, 1995; Razzaq, 1998; Memon et al., 1999). It 
seems important to find out its permanent remedial and 
preventive solution instead of recording its incidence 
and prevalence over and over again (Allore, 1993). 
Keeping in view the dairy farming scenario 
prevailing in Pakistan, the present study was planned to 
prepare and compare the efficacies of four Staph. 
aureus vaccines (viz. live attenuated, plain bacterin, 
dextran sulphate adjuvanted bacterin and oil-adjuvanted 
bacterin)  in rabbits as a first phase before their 
application in cows and buffaloes.  
 
MATERIALS AND METHODS 
 
Isolation of field isolate 
A specific culture of a field isolate of Staph. aureus 
was obtained from the Department of Clinical Medicine 
and Surgery, University of Agriculture, Faisalabad, 
Pakistan. It was recultured and recharacterized on Staph 
110 medium and Staph Track system (API-Staph Kit, 
USA), respectively. 
 
Pathogenicity of selected vaccinal isolate of Staph. 
aureus 
An activated growth (6-hours of incubation) of 
Staph. aureus from nutrient broth was adjusted to 10
6 
cells per ml in phosphate bufferred saline (PBS) using 
McFarland standard. A single dose of 0.25 ml was 
administered s/c to four healthy adult rabbits. All the 
animals were kept under observation for 24 hours 
(Machant and Packer, 1983).  
 
Optimization of cultural conditions 
Optimal cultural conditions were standardized in 
order to get the encapsulated Staph. aureus. For this 
purpose, the selected field isolate was grown on blood agar 
(BA) plate, nutrient broth (NB) modified NB, brain heart 
infusion broth (BHIB), and modified BHIB. Modification 
of NB and BHIB was done by incorporating bubaline 
sterile whey @ 10% v/v. Extent of the expression of the 
pseudocapsule in different cultural conditions was 
confirmed and compared by using autoagglutination 
method (Watson and Watson, 1989). 
 
Preparation of inactivated antigen 
The culture suspension was examined for purity 
through Grams’ staining method (Awan and Rahman, 
2005). Total bacterial count was calculated 
spectrophotometrically (U-2001, Model 121-0032, 
Hitachi Instruments, Inc. Japan) at 640 nm wave length. 
After adding formaline (0.2%), the broth was kept for 
12 hours at room temperature. Sterility of the 
suspension was assessed through cultural examination 
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on blood agar plate in next 24 hours and stored under 
refrigeration temperature for future use. 
 
Evaluation of antigenicity in rabbits 
Fifteen adult rabbits were divided into three equal 
groups. Rabbits of group R1 were inoculated with 0.2 
ml of inactivated antigen through subcuataneous route 
as single dose. Group R2 rabbits were inoculated with 
0.2 ml of inactivated antigen through subcutaneous 
route, followed by booster dose 7 days later. The 
rabbits of group R3 were kept as unvaccinated control. 
All the rabbits were maintained separately in the cages 
and given feed and water ad-libitum.  
Serum samples were collected from each group 
randomly from three rabbits at weekly intervals for 21 
days postinoculation. Antibody titers were measured 
using standard technique of indirect haemagglutination 
(IHA) test (Rahman et al., 2005). 
 
Evaluation of immune response  
A total of 15 adult rabbits (weighing approx. 2.5 
kg) were divided randomly into three equal groups (R4, 
R5, R6). Formaline inactivated antigen (Staph. aureus) 
was prepared in three different concentrations. The 
rabbits of group R4 were immunized with the formaline 
inactivated antigen preparation containing 10
8 cells/ml 
of Staph. aureus. The rabbits of group R5 were given 
preparation containing 10
10 cells/ ml, while group R6 
was administered with 10
12 cells per ml. Serum samples 
were collected at weekly intervals for three consecutive 
weeks from rabbits of all groups. Antibody response to 
different antigen concentrations was evaluated through 
IHA test (Rahman et al., 2005). 
 
Extraction of crude toxin and vaccines preparation  
For incorporation of crude extract, supernatant 
fluid was collected from 48-hour broth culture of Staph. 
aureus. The supernatant was separately autoclaved at 
121
oC for 20 minutes. This preparation was then 
centrifuged at 6000 x g for 30 minutes at 4°C and the 
supernatant was added to the vaccine preparation at a 
concentration of approximately 5 mg of dry weight per 
dose. Finally, the plain Staph. aureus vaccine was 
prepared (Giraudo et al., 1997). Formaline inactivated 
Staph. aureus was adjusted to 10
10 cells/ml 
spectrophotometrically at 640 nm wave length. Sodium 
azide was added as a preservative at final 
concentrations of 0.001% (w/v) and stored at 4
oC for 
future use (Watson and Davies, 1993).  
For dextran sulphate adjuvanted vaccine, dextran 
sulphate (DXS, sigma-Aldrich Co., USA) was added as 
an adjuvant in the plain vaccine at a final concentration 
of 50 mg DXS per ml for 5 ml dose (Watson and 
Davies, 1993). For oil-adjuvanted vaccine,  liquid 
paraffin was used as an adjuvant, whereas Tween-80 
and Span-80 were used as emulsifiers. Emulsification 
of oil and Span-80 was done at low speed (12000 rpm) 
with the help of ultra homogenizer (Ultraturex, USA). 
Antigen suspension was slowly added and continuously 
stirred at 180 × g in the ultra homogenizer at 4°C. Final 
oil emulsion vaccine was dispursed in sterilized glass 
vials with automatic cap seal system and stored at 4°C 
for future use (Shauket et al., 1998). 
For the preparation of live attenuated vaccine, an 
α-β haemolytic selected isolate of Staph. aureus was 
repeatedly passaged through culture on 5% sheep blood 
agar for 18
th passages until it lost its haemolytic activity 
and then maintained in trypticase soy broth. This live 
attenuated isolate was grown for 24 hours in nutrient 
broth. Organisms were pelleted by centrifugation (3000 
× g; 15 min.), washed (×2) with PBS (pH 7.2) and 
resuspended in sterile PBS. The concentration of 
bacteria was finally adjusted to 10
10 cells/ml using 
spectrophotometric method (Watson and Lee, 1978).  
 
Quality control  
Sterility of vaccines was confirmed through 
cultivation of vaccine preparations on blood agar plate 
and incubating for 48 hours for the absence of any 
growth. Safety of live and killed vaccines was 
examined by s/c inoculation of 2 ml of the vaccines into 
eight rabbits (2 rabbits per vaccine). 
To check the stability, sealed vials of inactivated 
Staph. aurues vaccines were kept at 4, 20 and 37
oC till 
nine months. Physical properties of these vaccines were 
recorded. Live attenuated Staph. aureus was stored into 
three different media (peptone water, PBS and nutrient 
broth) to assess the length of viability. The viability was 
assessed by standard plate count method (Awan and 
Rahman, 2005).  
 
Indirect haemagglutination test 
Indirect haemagglutination test (IHA), already 
standardized by Rahman et al. (2005), was adopted for 
the evaluation of immune response in rabbits. Sonicated 
Staph. aureus antigen was used to sensitize sheep RBCs 
along with gluateraldehyde used as coupling agent. One 
percent sensitized sheep RBCs were finally used for 
conducting IHA test. 
 
Immunogenicity trials  
Twenty five adult healthy rabbits were divided 
randomly into five equal groups (R7 to R11).  The 
rabbits of group R7 were vaccinated with live attenuated 
Staph. aureus vaccine. The rabbits of group R8 received 
plain bacterin. Rabbits of group R9 were given dextran 
sulphate adjuvanted vaccine. Rabbits of group R10 
received oil-adjuvanted vaccine, whereas the rabbits of 
group R11 were kept as unvaccinated control. Serum 
samples were collected fortnightly for two months from 
the rabbits of all groups and antibody respose was 
evaluated through IHA test (Rahman et al., 2005) 
 
RESULTS 
 
Biorecharacterization and pathogenicity of Staph. 
aureus isolate 
The selected typical alpha-beta isolate of Staph. 
aureus showed the same 7 digit API-Staph biochemical 
profile 6336153 when it was biotyped again. All the 
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rabbits died within 18 hours and postmortem 
examination indicated septicaemia and patachiation on 
the intestinal serosal surface, straw-colored fluid in 
abdomen and swollen kidneys. Stained blood and straw 
colored smear indicated Staph. aureus infection. 
Modified nutrient broth proved to be the best 
pseudocapsule developing medium in which autoagglu-
tination was observed in molar concentration solution 
of sodium hydroxide starting from 0.04 to 0.001, while 
partial agglutination was found in modified brain heart 
infusion broth in molar concentration solution of 
sodium hydroxide between 0.04 and 0.001. 
 
Antigenic response of Staph. aureus  
There was an apparent primary immune response in 
group R1, which was 17.0 at day 14, followed by a slight 
decrease at day 21. In group R2, there was a distinct 
primary and secondary immune response that was 8.0 at 
day 7 and was maximum (26.0) at day 21. There was no 
such response in unvaccinated control rabbits. 
 
Dose dependent immune response of Staph. aureus  
The trend of antibody production (GMT) was about 
the same in three groups (R4 to R6). It was maximum 
(32.0) at day 14 in group R5 and remained almost 
consistent till day 21. It was less (21.1) in group R4 
than that of group R6 in which antibody titer was 27.9 
at day 14 and 21.1 at day 21.  
The immunogenic response was highest in group 
R5 which was given the dose of 10
10/ml concentration, 
while it was the lowest in group R4. The immune 
response elicited by 10
12 cells/ml concentration was in 
between the response shown by the other two 
concentrations i.e. 10
8 and 10
10cells/ml. These results 
indicate that the rabbits of group R5 showed the best 
immune response and the concentration of Staph. 
aureus attained in this group was finalized in the 
preparation of  attenuated and adjuvanted mastitis 
vaccines.  
 
Immune response of four vaccines 
In R7 group, antibody titers (GMT) were 32.0 at 
day 15 and 84.4 at day 30 with a constant increase until 
day 45 (128), followed by a slight decrease (119.4) at 
day 60. For group R9, GMT was 32.0 at day 15 and 
was followed by a sharp increase (128.0) at day 30 with 
consistency till day 45. There was a slight decrease in 
antibody titer at day 60 when it was 119.4. For group 
R10 vaccinated with oil adjuvanted Staph. aureus 
vaccine, GMT was 16.0 at day 15 and was followed by 
an upward trend, reaching 64.0 at day 30 and showed 
this consistency until the 60th day after primary 
vaccination. 
In group R8 vaccinated with plain bacterin Staph. 
aureus vaccine, GMT was 16 at day 15 with a 
progressive trend to 32 at day 30 and it persisted till day 
45, then it showed a downward trend reaching 21.1 at 
day 60. There was no such trend in rabbits of 
unvaccinated control group. It is apparent that dextran 
sulphate adjuvanted Staph. aureus vaccine attained the 
higher peak antibody titer than that of live attenuated 
Staph. aureus vaccine, the latter showed similar 
antibody titer during the last 15 days of trial as that of 
live attenuated Staph. aureus vaccine. Live attenuated 
Staph. aureus vaccine acquired the highest antibody 
titer at day 45. A consistent sharp upward trend of 
antibody titer was observed from day 15 to 30 in 
dextran sulphate adjuvanted Staph. aureus vaccine. 
 
DISCUSSION 
 
After getting a typical bovine alpha-beta Staph. 
aureus  on rebiotyping, the same 7-digit biochemical 
profile was observed. This is in line with the standard 
methods of identification of this organism adopted by 
several workers (Gonzalez et al., 1989; Nickerson, 
1992; Chaudhry and Azam, 1995). It proved its 
pathogenicity and antigenicity in rabbits, as has 
previously been observed by Farooq et al. (2004).  A 
concentration of 10
10 cells/ ml was found to be more 
immunogenic as compared to other concentrations 
tested. A concentration of 10
12/ml was immuno-
suppressive initially contrary to the other two 
concentrations. Therefore, an increase in concentration 
above 10
10 cells /ml did not enhance the immune 
response, rather a decrease was observed. Several other 
workers (Opdebeeck and Norcross, 1985; Watson and 
Davies, 1993) conducted dose dependent trails of 
Staph. aureus in rabbits and concluded that a concen-
tration above 10
10/ml
 did not elicit a significantly higher 
immune response. 
In the present study, autoagglutination test proved 
its worth as a preliminary test in detecting the 
pseudocapsule of the vaccinal Staph. aureus which  is 
in line with the findings of Watson and Watson (1989), 
who found that organisms grown inside the udder, or in 
nutrient broth supplemented with ovine, caprine or 
bovine milk whey, produced a large, well defined 
pseudocapsule outside the cell wall. Staph. aureus 
grown in the presence of milk whey should have a 
strong propensity to autoagglutinate and produce 
pseudocapsular material, which contained antigens in 
common with staphylococci grown in vivo.  
A better response was elicited by rabbits given live 
attenuated Staph. aureus vaccine (LSAV). Watson and 
Prideaux (1979) concluded that following 
immunization with a live Staph. aureus vaccine, the 
organisms multiply in the skin or tissues and an abscess 
develops.  In rabbits vaccinated with either of four 
vaccines or kept as control, the highest antibody titers 
against Staph. aureus were recorded in those given the 
vaccine containing dextran sulphate  as an adjuvant 
(Dextran sulphate adjuvanted Staph. aureus vaccinie-
DSAV). This is in agreement with the finding of Han 
and Park (2000).  
In this study, Staph. aureus plain bacterin elicited 
lowest HIA antibody titer in the rabbits vaccinated with 
simple bacterin. The animals of group R8 receiving 
plain bacterin showed the less peak titers than the other 
three (LSAV, DSAV and OSAV), followed by a sharp 
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decline which is in line with the findings of Watson and 
Prideaux (1979). 
Oil adjuvanted Staph. aureus vaccinated (OSAV) 
group (R10) gained the peak titer slowly, followed by a 
persistency. Watson (1987) and Nordhaug et al. (1994) 
ascribed it to the mineral oil component of the vaccine, 
which constituted a depot from which vaccine 
components were slowly released.  
A higher titer at day 30, followed by sharp decline 
at day 5 and day 0 in rabbits of group R3 concur with 
the pattern of antibody titers in sheep. It has been 
observed that addition of dextran sulphate to the 
vaccine provoked significantly higher antibody 
response that sustained for a longer period in sheep 
(Watson, 1987; Watson and Davies, 1993).  
In conclusion, Staph aureus vaccines were found 
safe and effective in stimulating the serum antibody 
titers against the vaccinal isolate. These four vaccines 
may be tried in other species i.e. cows and buffaloes to 
control Staph. aureus mastitis in these species. 
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